Genomic Health's Second Quarter Was So Great It Got the Company Acquired
Genomic Health (NASDAQ: GHDX) announced its earnings a few days ahead of schedule because it had much bigger news to share with investors: The company is being acquired by Exact Sciences (NASDAQ: EXAS) for $72 per share, consisting of $27.50 in cash and $44.50 in shares of Exact Sciences stock that's subject to adjustment based on Exact Sciences' share price movement.
Metric
Q2 2019
Quelle Fool.com
